Law ❯ Securities Law

Investor Rights

Class Action Litigation Legal Representation Class Action Lawsuits Corporate Governance Class Action Lawsuit Class Action Litigation Legal Counsel Lead Plaintiff Process Whistleblower Programs Litigation Process Fraud Corporate Accountability Legal Claims Class Action Claims Fraudulent Misrepresentation Legal Proceedings Fraud Allegations Legal Consultation Misleading Claims Shareholder Actions Class Action Procedures Securities Investigations Class Action Eligibility

Microvast Investors Face Sept. 21 Deadline to Seek Lead Role in Federal Securities Suit

The deadline will determine which investor will steer the lawsuit through court and settlement negotiations.

Securities Suit Targets Insulet Over Omnipod Manufacturing Disclosures

Class Action Targets Bloom Energy Over Alleged Hidden China Link in Scandium Supply

Securities Suits Target BitGo After IPO as Firms Race to Lead Litigation

Multiple Law Firms Seek Lead Role in ADMA Biologics Securities Suit After Short‑seller Report

Securities Class Action Filed Against Badger Meter as Firms Seek Lead Plaintiffs

Veritone Admits Q3 2025 Revenue Accounting Errors and Draws Multiple Investor Lawsuits

Investors File Securities Suit Over Graphic Packaging Inventory Problems

Securities Class Action Filed Against Commvault Over ARR Disclosure Practices

Multiple Law Firms Press Investors to Join Securities Suit Over AeroVironment Space Contracts

Multiple Plaintiff Firms Press Investors to Lead FS KKR Capital Securities Lawsuit

Shareholder Class Action Filed Against Phreesia After Guidance Cut

Multiple Firms Seek Lead Role in Securities Suit Over Commvault’s ARR Shortfall

Investors File Securities Suit Against Regencell as Firms Seek Lead Plaintiff

Securities Suit Filed Over Stellantis’ €22.2 Billion ‘Reset’ as Firms Race to Be Lead Plaintiff

Gossamer Bio Faces Class Actions After Phase 3 PROSERA Misses Primary Endpoint

FS KKR Capital Sued in Securities Class Action as Firms Seek Lead Plaintiff

Law Firms Court Globant Investors Ahead of June 23 Lead‑Plaintiff Deadline

Regeneron Slides as Melanoma Combo Fails to Beat Keytruda in Phase 3

Oddity Tech Investors Face Monday Deadline To Seek Lead Role in Securities Case